Wells Fargo & Company Neoleukin Therapeutics, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.68 - $0.91 $7 - $10	11 Added 0.13%	8,244 $6,000
Q1 2023 May 12, 2023	BUY	$0.5 - $0.72 $2 - $2	4 Added 0.05%	8,233 $5,000
Q4 2022 Feb 13, 2023	BUY	$0.4 - $0.55 $2 - $3	6 Added 0.07%	8,229 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.69 - $1.33 $2 - $5	4 Added 0.05%	8,223 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $2,985 - $7,301	-3,245 Reduced 28.31%	8,219 $8,000
Q1 2022 May 16, 2022	SELL	$1.72 - $5.23 $22,721 - $69,088	-13,210 Reduced 53.54%	11,464 $22,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $70,233 - $117,056	15,104 Added 157.83%	24,674 $118,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $14,520 - $23,184	-2,400 Reduced 20.05%	9,570 $69,000
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $27,126 - $38,559	-2,939 Reduced 19.71%	11,970 $110,000
Q1 2021 May 13, 2021	SELL	$11.26 - $15.78 $404,774 - $567,259	-35,948 Reduced 70.68%	14,909 $184,000
Q4 2020 Feb 09, 2021	BUY	$10.17 - $14.56 $17,339 - $24,824	1,705 Added 3.47%	50,857 $717,000
Q3 2020 Nov 05, 2020	SELL	$9.68 - $17.01 $69,531 - $122,182	-7,183 Reduced 12.75%	49,152 $591,000
Q2 2020 Aug 13, 2020	BUY	$9.95 - $17.05 $558,175 - $956,470	56,098 Added 23670.04%	56,335 $936,000
Q1 2020 May 14, 2020	BUY	$6.12 - $13.64 $1,450 - $3,232	237 New	237 $3,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.